Roche reports solid results in the first quarter of 2021

NEXT STORY
Helsinn Announces the Launch of Adlumiz® (anamorelin) for the Treatment of Cancer Cachexia in Japan
PREV STORY
El NOBLE Registry – Una colaboración internacional para el desarrollo de imágenes SPECT iPSMA para el cáncer de próstata
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aegea Biotechnologies, Inc. Announces the Issuance of 7 Additional Key U.S. Patents Relating to its Core, Next Generation Nucleic Acid Clinical Diagnostic Technologies and COVID-19 Test Development

author_avatar
NASDAQ Market News

UPDATE — Reset Pharmaceuticals Enters into Exclusive Worldwide License Agreement with NYU Langone Health for Intellectual Property and Data on Psilocybin and Related Psychedelics for the Treatment of Mental Illness in Patients with Life-Threatening Diseases, Including Cancer

author_avatar
NASDAQ Market News

Sanofi provides update on Phase 3 study evaluating rilzabrutinib for the treatment of pemphigus

author_avatar
NASDAQ Market News